November 17, 2025
Ismail Elkhatib
Share
Semaglutide Improves Histology in MASH: Phase 3 ESSENCE Trial
January 20, 2026
Can seladelpar serve as second-line treatment for PBC patients with inadequate UDCA therapy?
October 27, 2025
HepMadness
October 15, 2025